Profile data is unavailable for this security.
About the company
Shanghai MicuRx Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development (R&D) and commercialization of innovative drugs. The Company's antibacterial drug product, contezolid tablets, can be applied to treat infections caused by multidrug-resistant gram-positive bacteria. The Company also has a number of new anti-drug-resistant bacteria, kidney cancer, nephritis drugs and anti-new crown drug pipelines in the preclinical stage, including MRX-4, MRX-5, MRX-7, MRX-15, MRX-17 and others. The Company operates its businesses primarily in the domestic market.
- Revenue in CNY (TTM)106.52m
- Net income in CNY-467.10m
- Incorporated2012
- Employees205.00
- LocationShanghai MicuRx Pharmaceutical Co LtdSHANGHAI 201210ChinaCHN
- Phone+86 2 150900550
- Fax+86 2 161101898
- Websitehttp://www.micurxchina.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shanghai Shenqi Pharmactcl Inv Mgt CoLtd | 2.33bn | 57.15m | 2.68bn | 1.43k | 45.05 | 1.18 | -- | 1.15 | 0.1159 | 0.1159 | 4.37 | 4.42 | 0.7213 | 5.74 | 5.75 | 1,635,818.00 | 1.86 | -0.6002 | 2.33 | -0.7417 | 47.59 | 56.64 | 2.57 | -0.9128 | 2.34 | 12.17 | 0.104 | -- | -2.00 | 4.79 | 17.41 | -11.68 | -25.97 | -- |
Obio Technology Shanghai Corp Ltd | 233.59m | -138.37m | 2.75bn | 731.00 | -- | 1.36 | -- | 11.75 | -0.2157 | -0.2157 | 0.3624 | 3.11 | 0.0921 | 3.37 | 2.52 | 319,545.50 | -5.45 | 0.2246 | -5.99 | 0.2514 | -9.53 | 36.72 | -59.21 | 1.48 | 2.39 | -- | 0.1103 | 0.00 | -29.69 | 35.88 | -425.90 | -- | 57.00 | -- |
Shanghai Fudan Forward S&T Co Ltd | 665.16m | -6.01m | 2.77bn | 1.36k | -- | 3.48 | -- | 4.17 | -0.0089 | -0.0089 | 0.9791 | 1.16 | 0.3776 | 0.6066 | 8.47 | 488,010.90 | -0.3031 | -0.8781 | -0.5073 | -1.53 | 40.85 | 43.22 | -0.8027 | -1.85 | 0.4956 | -1.83 | 0.3817 | -- | -13.86 | -7.58 | 196.17 | -32.57 | -13.88 | -- |
Shanghai MicuRx Pharmaceutical Co Ltd | 106.52m | -467.10m | 2.85bn | 205.00 | -- | 3.84 | -- | 26.76 | -0.7129 | -0.7129 | 0.1626 | 1.13 | 0.0839 | 0.5802 | 5.74 | 519,588.20 | -36.81 | -- | -40.09 | -- | 81.75 | -- | -438.53 | -- | 6.94 | -- | 0.2497 | -- | 88.31 | -- | -91.16 | -- | -- | -- |
Data as of Jul 30 2024. Currency figures normalised to Shanghai MicuRx Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
6.81%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 13.89m | 4.02% |
Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 3.23m | 0.94% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 2.24m | 0.65% |
Gfund Management Co., Ltd.as of 31 Dec 2023 | 1.89m | 0.55% |
Huatai-PineBridge Fund Management Co., Ltd.as of 31 Dec 2023 | 500.40k | 0.15% |
Manulife TEDA Fund Management Co., Ltd.as of 31 Dec 2023 | 463.13k | 0.13% |
Orient Securities Asset Management Co. Ltd.as of 31 Dec 2023 | 449.10k | 0.13% |
Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 295.58k | 0.09% |
Hongde Fund Management Co., Ltd.as of 31 Dec 2023 | 292.30k | 0.09% |
CPIC Fund Management Co. Ltd.as of 31 Dec 2023 | 276.79k | 0.08% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.